Literature DB >> 17607368

Non-specific effects of siRNAs on tumor cells with implications on therapeutic applicability using RNA interference.

Darjus Tschaharganeh1, Volker Ehemann, Tanja Nussbaum, Peter Schirmacher, Kai Breuhahn.   

Abstract

Elimination of protein expression using RNA interference (RNAi) significantly improves the understanding of gene function and represents a promising technique for the treatment of diseases such as cancer and neurological disorders. Accumulating evidence suggests the so-called interferon-independent non-specific gene silencing of short interfering RNA (siRNA); however, its biological and functional cellular consequences are largely unidentified. We therefore analyzed the effects of different nonsense siRNAs on characteristic bio-parameters such as cell viability, proliferation, cell cycle distribution, apoptosis, and migration of tumor cells. All analyzed cellular aspects have been observed to be significantly affected by the presence of siRNA in an interferon-independent manner: viability, mitosis, and motility were significantly diminished and programmed cell death was significantly elevated. Moreover, all cell cycle stages (G0/G1-, G2/M-, and S-phase) were moderately shifted. Together, these results support the hypothesis that siRNA, due to sequence-specific cellular consequences, modulate bio-functionality independent of the target sequence. This phenomenon affects the design of siRNA experiments for future in vitro but also for in vivo tests as well as for potential therapeutic and preventive strategies. Moreover, monitoring interferon response after transfection of siRNAs is necessary but not sufficient to exclude potential off-target effects in non-diseased cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17607368     DOI: 10.1007/bf02893482

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  22 in total

1.  Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate.

Authors:  S M Elbashir; J Martinez; A Patkaniowska; W Lendeckel; T Tuschl
Journal:  EMBO J       Date:  2001-12-03       Impact factor: 11.598

Review 2.  RNA interference in protozoan parasites.

Authors:  Elisabetta Ullu; Christian Tschudi; Tirtha Chakraborty
Journal:  Cell Microbiol       Date:  2004-06       Impact factor: 3.715

3.  Position-specific chemical modification of siRNAs reduces "off-target" transcript silencing.

Authors:  Aimee L Jackson; Julja Burchard; Devin Leake; Angela Reynolds; Janell Schelter; Jie Guo; Jason M Johnson; Lee Lim; Jon Karpilow; Kim Nichols; William Marshall; Anastasia Khvorova; Peter S Linsley
Journal:  RNA       Date:  2006-05-08       Impact factor: 4.942

4.  Widespread siRNA "off-target" transcript silencing mediated by seed region sequence complementarity.

Authors:  Aimee L Jackson; Julja Burchard; Janell Schelter; B Nelson Chau; Michele Cleary; Lee Lim; Peter S Linsley
Journal:  RNA       Date:  2006-05-08       Impact factor: 4.942

Review 5.  RNA interference-mediated prevention and therapy for hepatocellular carcinoma.

Authors:  P R Romano; D E McCallus; C J Pachuk
Journal:  Oncogene       Date:  2006-06-26       Impact factor: 9.867

6.  Evidence that siRNAs function as guides, not primers, in the Drosophila and human RNAi pathways.

Authors:  Dianne S Schwarz; György Hutvágner; Benjamin Haley; Phillip D Zamore
Journal:  Mol Cell       Date:  2002-09       Impact factor: 17.970

7.  Allele-specific RNAi selectively silences mutant SOD1 and achieves significant therapeutic benefit in vivo.

Authors:  Xugang Xia; Hongxia Zhou; Yong Huang; Zuoshang Xu
Journal:  Neurobiol Dis       Date:  2006-07-20       Impact factor: 5.996

8.  Flow cytometric DNA analysis and chromosomal aberrations in malignant glioblastomas.

Authors:  V Ehemann; B Hashemi; A Lange; H F Otto
Journal:  Cancer Lett       Date:  1999-04-26       Impact factor: 8.679

9.  Fundamental study of small interfering RNAs for ganglioside GD3 synthase gene as a therapeutic target of lung cancers.

Authors:  K Ko; K Furukawa; T Takahashi; T Urano; Y Sanai; M Nagino; Y Nimura; K Furukawa
Journal:  Oncogene       Date:  2006-07-24       Impact factor: 9.867

10.  Double-stranded RNA-dependent protein kinase activates transcription factor NF-kappa B by phosphorylating I kappa B.

Authors:  A Kumar; J Haque; J Lacoste; J Hiscott; B R Williams
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-05       Impact factor: 11.205

View more
  9 in total

1.  Triptolide-induced apoptosis by inactivating nuclear factor-kappa B apoptotic pathway in multiple myeloma in vitro.

Authors:  Rong Zeng; Linlan Zeng; Yan Chen; Fei Zhao; Rui Li; Lu Wen; Chun Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-08-07

2.  Reversing multidrug-resistant by RNA interference through silencing MDR1 gene in human hepatocellular carcinoma cells subline Bel-7402/ADM.

Authors:  Long Sheng; Maoming Xiong; Cong Li; Xiangling Meng
Journal:  Pathol Oncol Res       Date:  2013-12-11       Impact factor: 3.201

3.  NF-κB mediates radio-sensitization by the PARP-1 inhibitor, AG-014699.

Authors:  J E Hunter; E Willmore; J A E Irving; Z Hostomsky; S J Veuger; B W Durkacz
Journal:  Oncogene       Date:  2011-06-27       Impact factor: 9.867

4.  Treatment of glioblastoma multiforme cells with temozolomide-BioShuttle ligated by the inverse Diels-Alder ligation chemistry.

Authors:  Klaus Braun; Manfred Wiessler; Volker Ehemann; Ruediger Pipkorn; Herbert Spring; Juergen Debus; Bernd Didinger; Mario Koch; Gabriele Muller; Waldemar Waldeck
Journal:  Drug Des Devel Ther       Date:  2009-02-06       Impact factor: 4.162

5.  TMZ-BioShuttle--a reformulated temozolomide.

Authors:  Waldemar Waldeck; Manfred Wiessler; Volker Ehemann; Ruediger Pipkorn; Herbert Spring; Juergen Debus; Bernd Didinger; Gabriele Mueller; Joerg Langowski; Klaus Braun
Journal:  Int J Med Sci       Date:  2008-09-15       Impact factor: 3.738

6.  Silencing of keratinocyte growth factor receptor restores 5-fluorouracil and tamoxifen efficacy on responsive cancer cells.

Authors:  Sabrina Rotolo; Simona Ceccarelli; Ferdinando Romano; Luigi Frati; Cinzia Marchese; Antonio Angeloni
Journal:  PLoS One       Date:  2008-06-25       Impact factor: 3.240

Review 7.  Chinese herb related molecules of cancer-cell-apoptosis: a minireview of progress between Kanglaite injection and related genes.

Authors:  Yun Lu; Chang-Sheng Li; Qian Dong
Journal:  J Exp Clin Cancer Res       Date:  2008-08-21

8.  High-resolution flow cytometry: a suitable tool for monitoring aneuploid prostate cancer cells after TMZ and TMZ-BioShuttle treatment.

Authors:  Klaus Braun; Volker Ehemann; Manfred Wiessler; Ruediger Pipkorn; Bernd Didinger; Gabriele Mueller; Waldemar Waldeck
Journal:  Int J Med Sci       Date:  2009-11-18       Impact factor: 3.738

9.  Reproducibility and cell biology.

Authors:  Kenneth M Yamada; Alan Hall
Journal:  J Cell Biol       Date:  2015-04-27       Impact factor: 10.539

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.